Corporate Finance
The Peptide Boom: Where Big Pharma Meets the Grey Market
Download PDF Introduction The success of GLP-1 drugs, most notably Ozempic and Mounjaro, has made peptides one of the most commercially attractive therapeutic areas in the world and, therefore, a key pillar in Big Pharma’s strategy moving forward. Peptides, short chains of amino acids between traditional small-molecule drugs and larger Read more…
